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INTRODUCTION
Our multidisciplinary team developed a 
perioperative amiodarone protocol based on 
published data. 
This protocol was initiated for all patients 
undergoing open-heart surgery, starting in 
the operating room and continuing through 
their stay at the hospital. 
After getting approval from our IRB, a 
database was created for a retrospective 
chart review of patients 2 months prior 
to, and 4 months following the protocol 
initiation date. 
Univariate analysis and multivariate regres-
sions were conducted to compare patient 
demographics, POAF risk factors, presence 
of POAF, length of stay, and mortality. 
Post-operative atrial fibrillation (POAF) 
following open-heart procedures affects 30-
50% of patients. It’s presence has negative 
prognostic indications for the patient. 
Advanced age is associated with higher 
incidence of POAF, making it a potentially 
growing problem.
Complications include increased morbidity, 
mortality, length of stay, and as a result 
increased resource utilization. 
The most effective prophylactic medication 
for cardiac procedures is amiodarone, shown 
to be superior for preventing and treating 
atrial fibrillation. 
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METHODS
Population
242 total patients, 146 (60%) on protocol. 
Median age was 68 (IQR 59-73), 73% were 
male, and the majority of operations were 
CABG (46%), Valve (32%), or Combined 
(20%). 
Risk Factors for Atrial Fibrillation
Of the 10 risk factors observed, 
hypertension, CHF, male sex, and advanced 
age (>70 years) were the most common. 
Incidence of Atrial Fibrillation
Overall incidence of POAF was 40%, 
protocol patients had a 26% relative risk 
reduction (35% vs 47%), however the 
difference was statistically insignificant 
(p=0.06). CABG patients had the most 
significant decrease in POAF rates (22% 
vs 37%, p=0.03), but all three of the 
major procedures had relatively large risk 
reductions. Patients with history of A-fib 
and pulmonary HTN had the largest relative 
risk reduction (42% and 51%, respectively).
RESULTS
Length of Stay
Amiodarone protocol patients had a 
decreased average length of stay (LOS) of 
6.8 days compared to 9.0 days, p-value 
< 0.001. Protocol patients who did not 
develop POAF had a significantly decreased 
LOS compared to their non-protocol 
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The aim of this investigation is to improve 
the outcomes in open-heart surgery patients 
by initiating amiodarone prophylaxis regimen 
during the perioperative period. 
PROBLEM STATEMENT
CONCLUSION
The addition of our anti-arrhythmia 
prophylaxis protocol to the standard of care 
for all open-heart surgery patients resulted 
in a decreased length of stay, relatively 
decreased rate of POAF in ALL procedure 
patients, and a significantly decreased POAF 
rate in CABG patients. 
FUTURE DIRECTIONS
•  Protocol will remain in place and 
expansion into full treatment algorithm 
•  Cost/benefit analysis to be performed 
Thie significant results coming from this data 
were that the initiaion of our amiodarone 
protocol resulted in a decreased total length 
of stay and decreased incidence of POAF 
in CABG patients. Overall POAF rates were 
improved, although this was not statistically 
significant.
These resuls are an improvement for the 
patient as it denotes earlier recovery and 
decreased risk for iatrogenic illnesses, it also 
is a large saviang for the hospital in a form 
of resource and cost.
Mortality
There were 4 deaths (4%) in the non-
protocol group and 3 (2%) deaths in the 
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